Insiders · Profile

Rhodes Jennifer J

EVP, CHIEF LEGAL OFFICER, SEC at ACADIA PHARMACEUTICALS · See Remarks at Elicio Therapeutics. Filing since 13 Feb 2021. CIK 0001568249

ACAD ACADIA PHARMACEUTICALS INC EVP, CHIEF LEGAL OFFICER, SEC · 2 trades ELTX Elicio Therapeutics, Inc. See Remarks · 12 trades

Company

Date

Role

Action

Shares

Amount

Of holding

ACAD ACADIA PHARMACEUTICALS INC

25 Mar 2026

EVP, CHIEF LEGAL OFFICER, SEC

Sold at will

3,844

$82.53K

25.4%

ACAD ACADIA PHARMACEUTICALS INC

9 Feb 2026

EVP, CHIEF LEGAL OFFICER, SEC

Sold at will

6,950

$162.49K

47.7%

ELTX Elicio Therapeutics, Inc.

14 Dec 2021

See Remarks

Sold, plan not stated

451

$1.09K

1.5%

ELTX Elicio Therapeutics, Inc.

15 Nov 2021

See Remarks

Sold, plan not stated

433

$1.91K

1.4%

ELTX Elicio Therapeutics, Inc.

14 Oct 2021

See Remarks

Sold, plan not stated

430

$3.72K

1.4%

ELTX Elicio Therapeutics, Inc.

14 Sep 2021

See Remarks

Sold, plan not stated

430

$4.58K

1.3%

ELTX Elicio Therapeutics, Inc.

16 Aug 2021

See Remarks

Sold, plan not stated

445

$4.75K

1.4%

ELTX Elicio Therapeutics, Inc.

21 Jul 2021

See Remarks

Sold, plan not stated

432

$4.73K

1.3%

ELTX Elicio Therapeutics, Inc.

14 Jul 2021

See Remarks

Sold, plan not stated

431

$4.75K

1.3%

ELTX Elicio Therapeutics, Inc.

14 Jun 2021

See Remarks

Sold, plan not stated

427

$5.67K

1.3%

ELTX Elicio Therapeutics, Inc.

14 May 2021

See Remarks

Sold, plan not stated

440

$6.12K

1.3%

ELTX Elicio Therapeutics, Inc.

15 Apr 2021

See Remarks

Sold, plan not stated

399

$5.99K

1.2%

ELTX Elicio Therapeutics, Inc.

13 Mar 2021

See Remarks

Sold, plan not stated

499

$10.20K

1.4%

ELTX Elicio Therapeutics, Inc.

13 Feb 2021

See Remarks

Sold, plan not stated

457

$8.93K

1.3%

14 decisions on file.